February 22, 2016Biomarkers

The role of cardiac biochemical markers in aortic stenosis

View Full Paper

Ask AI

Bookmark

Population

Patients with aortic stenosis

Design

Review

Authors

CCCalvin ChinCardiac Imaging ADAndie Hartanto DjohanNg Teng Fong General Hospital CLChim C. LangHeart Failure / Cardiomyopathy

Discussion

Member takes

Implication

Cardiac biomarkers merit prospective validation for LV decompensation in AS; leaves open their clinical role pending randomized data.

Structured PICO

Population

Patients with aortic stenosis

Intervention

Cardiac biochemical markers (BNP/NT-proBNP, markers of collagen metabolism, galectin-3, soluble ST2, high-sensitivity cardiac troponins, heart-type fatty acid binding protein, myosin-binding protein C)

This review summarizes the mechanisms and future directions of cardiac biochemical markers as objective measures of left ventricular decompensation in aortic stenosis.

Cite This Study

Chin et al. (2016) studied this question.

synapsesocial.com/papers/6a0f95ee2badbc352afe629a https://doi.org/10.3109/1354750x.2016.1141993

View Full Paper

Ask AI

Bookmark

The role of cardiac biochemical markers in aortic stenosis

Discussion

Member takes

Implication

Structured PICO

Cite This Study

The role of cardiac biochemical markers in aortic stenosis

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider